Sol-Gel Technologies Ltd. Ordinary Shares earnings per share and revenue
On Mar 23, 2026, SLGL reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of 0.39 USD, resulting in a --% surprise. Revenue reached 696.00 thousand, compared to an expected 6.63 million, with a -89.50% difference. The market reacted with a +20.86% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -1.87 USD, with revenue projected to reach 918.00 thousand USD, implying an -- of --% EPS, and increase of 31.90% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Taysha Gene Therapies, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.08
Surprise
+18.45%
Assembly Biosciences, Inc
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.66
Actual
$2.48
Surprise
+474.06%
FAQ
What were Sol-Gel Technologies Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Sol-Gel Technologies Ltd. Ordinary Shares reported EPS of --, missing estimates by --, and revenue of $696.00K, -89.5% below expectations.
How did the market react to Sol-Gel Technologies Ltd. Ordinary Shares's Q4 2025 earnings?
The stock price moved up 20.86%, changed from $66.20 before the earnings release to $80.01 the day after.
When is Sol-Gel Technologies Ltd. Ordinary Shares expected to report next?
The next earning report is scheduled for May 21, 2026.
What are the forecasts for Sol-Gel Technologies Ltd. Ordinary Shares's next earnings report?
Based on 3
analysts, Sol-Gel Technologies Ltd. Ordinary Shares is expected to report EPS of -$1.87 and revenue of $918.00K for Q1 2026.